Cancer · US
Cancer · US · 22 stories in 48h · Clear all filters
-
Bloomberg
Sellas Life Sciences Stock Triples After Cancer Vaccine DataSellas Life Sciences Group Inc. surged after the drug developer reported positive late-stage trial results for an experimental…
-
My family history of cancer was giving me so much anxiety. I finally learned to stop turning to Dr. Google.Every medical test triggered my fear of cancer, and searching my symptoms online made it worse. I had…
- Nasdaq.com Axe Compute Inc. Reports Third Quarter 2026 Financial ResultsPredictive Oncology Inc. (operating as Axe Compute Inc.) reported its financial results for the third quarter ended September…
- Seeking Alpha Lilly inks oncology licensing deal worth up to $5.9B with Stipple Bio
- Nasdaq.com bioAffinity Technologies, Inc. Reports Record Monthly Testing Volume in October 2026 for CyPath LungbioAffinity Technologies, Inc. announced that a record number of CyPath® Lung tests were performed in October 2026, marking…
-
Alphabet's Isomorphic Labs Raises $5 Billion In Sequoia-Led Funding RoundThe company says it's now near preclinical studies for its first oncology program.
- Nasdaq.com Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal CancerAdagene Inc. and City of Hope have announced the launch of an investigator-initiated Phase 1 clinical trial to…
-
SELLAS Life Sciences stock soars 240% on positive cancer trial
-
I founded a cancer biotech company. Then, my mom, dad, and I were all diagnosed with cancer.Dr. Ryan Beal is the CEO of Dyve, a cancer-biotech company. He, his dad, and his mom have…
-
Pancreatic cancer mystery deepens as researchers make unexpected discoveryUniversity of Cincinnati study found Black patients' pancreatic tumors had more B cells and cells tied to drug…
-
BeOne Medicines at Jefferies: oncology shift broadens beyond BRUKINSA
-
Novartis wins FDA approval for Cosentyx in polymyalgia rheumatica
- Ynetnews Weight-loss drug Wegovy shows promising results in children as young as 6, major study finds
-
Reuters
Lilly signs cancer research deal with Stipple Bio worth up to $5.9 billion
-
RNZ
'Ticking timebomb': Breast cancer survivor launches petition for mandatory tissue reportingDense breast tissue can hide or mask signs of cancer on standard mammograms, because the tissue shows up…
-
US stocks: Summit shares drop after US FDA declines to approve lung cancer drugSummit Therapeutics faced a notable decline in share value following the FDA's ruling on ivonescimab, which revealed insufficient…
-
Six-year-olds: Novo’s new frontier for weight-loss drugsWegovy helped almost 8 in 10 children as young as 6 lose more than 10% of their BMI…
-
The FDA declined to approve one of biotech’s most closely watched cancer drugsThe regulator told Summit Therapeutics that the lung-cancer drug needs to prove it can help people live longer.
-
Bloomberg
William and Kate Begin India Tour With Cricket and ClimateBritain’s Prince William and Kate Middleton began a three-day visit to India with a game of street cricket…
-
Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setbackShares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US…
-
A positive HPV test does not mean you have cervical cancer. Here's what to knowMost human papillomavirus (HPV) infections clear naturally, but some strains can cause changes in cervical cells that may…
-
Kura Oncology CEO Troy Wilson buys $1.5M in shares
8 more stories in other languages (Portuguese 4, Spanish 3, French 1) ·